22nd Annual Women of Action Celebration

Sunday, May 26, 2024 | 11:00 am Fairmont Royal York

About Israel Cancer Research Fund

The Answer to Cancer is Research

  • Brilliant Minds

    Meet Dr. Ronit Saatchi-Fainaro!

    Watch her webinar

  • ICRF Donor Recognition Park

    Ramat Aviv, Israel

  • Dr. Tal Falick Michaeli

    She's paving the way in Colorectal Cancer research!

    Learn more

  • Dr. Ruth Sherz-Shouval

    Learn more about her research!

    Watch the video

We harness the knowledge, educational resources, and research of Israels’ best and brightest scientists in order to save the lives of cancer patients in Toronto, North America and throughout the world.


ICRF has funded scientists who went on to discover incredible medical breakthroughs. Two of our very own ICRF-funded scientists (Professors Avram Hershko and Aaron Ciechanover of the Technion-Israel Institute of Technology) were nominated for and received the 2004 Nobel Prize in chemistry.


To date, ICRF has contributed more than USD $93,000,000 for over 2,800 grants involving all major hospitals, universities and cancer research projects throughout Israel.


The results of the research have a significant impact in Toronto, across Canada and throughout the world.


WHY ISRAEL CANCER RESEARCH FUND?

Your Gift Goes Further

Research in Israel carries less overhead than North American research and funds are allocated directly to our scientists in their labs. 

Startup Nation

Israel is a global powerhouse for innovation and entrepreneurialism.

Diversified Research

ICRF is currently funding 83 researchers across 11 institutions in Israel working on all areas of cancer research.

"I have a naïve faith that the answer to cancer will come from Israel, because Israel has given to humanity a concept of celebrating life. What you are doing is of extraordinary meaning and importance: first of all to save lives. Is there anything more noble in the whole world?"


- Elie Weisel



OUR SUCCESSES

Doxil® 

This cancer drug works overtime to treat ovarian, breast and AIDS-related cancers.

RAD 51

Used to identify the likelihood of breast cancer occurring in women who carry the BRCA 2 gene.

The Ubiquitin System

This discovery led to development of the miracle drug Velcade® for treatment of multiple myeloma.

Israel Winning the Nobel Prize

 ICRF funded professors Avram Hershko and Aaron Ciechanover won for their discovery of the Ubiquitin System. Their research resulted in the development of the drug Velcade® named “The Top Medical Breakthrough of 2003” by the Wall Street Journal.

Want to learn more?

Our researchers are tirelessly working to find new treatments and cures for all forms of cancer.


Learn about our new discoveries as they happen and join our ICRF Newsletter mailing list below!

Join our mailing list www.icrf.ca
Share by: